Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2020064692 - UTILISATION D'HISTIDINE, DE GLYCINE ET D'AUTRES ACIDES AMINÉS POUR PRÉVENIR LA RÉSISTANCE À L'INSULINE ET/OU LE DIABÈTE


Avertissement La version image (PDF) disponible dans PATENTSCOPE est la version officielle. Cette version HTML en ligne est fournie pour aider les utilisateurs. Malgré le grand soin apporté à la compilation pour assurer une représentation précise et exacte des données figurant sur le document/les images imprimés, des erreurs et/ou des omissions ne peuvent pas être exclues en raison des processus de transmission et de conversion de données et des limitations inhérentes aux processus de traduction (éventuellement) automatique utilisés. Les liens hypertexte suivis de ce symbole sont associés à des ressources externes qui ne sont pas contrôlées par l'OMPI. L'OMPI décline toute responsabilité concernant les points mentionnés ci-dessus.

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/EP2019/075640 16680-WO-PCT
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
24 September 2019 27 September 2018
Applicant
SOCIETE DES PRODUITS NESTLE S.A.
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
USE OF HISTIDINE, GLYCINE AND OTHER AMINOACIDS FOR PREVENTING INSULIN RESISTANCE AND/OR DIABETES

5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No. ____________
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     A61K 31/198 (2006.01)i; A61K 31/4172 (2006.01)i; A23L 33/175 (2016.01)i; A61P 3/08 (2006.01)i; A61P 3/10 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     A61K; A23L; A61P
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal, BIOSIS

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
Y
MARIO LAURIA ET AL, "Consensus Clustering of temporal profiles for the identification of metabolic markers of pre-diabetes in childhood (EarlyBird 73)", SCIENTIFIC REPORTS,Vol. 8, No. 1, 23 January 2018 (2018-01-23), page 1-16,
XP055557451
1-16
the whole document
(2)
Y
HOSKING J ET AL, "308 Longitudinal analysis of serum metabolite phenotypes in the Earlybird cohort identify metabolic readouts associated with childhood insulin resistence", Vol. 61, No. Suppl 1, 21 August 2018 (2018-08-21), page S156, DIABETOLOGIA, SPRINGER, BERLIN, DE
Retrieved from the Internet:
URL:https://link.springer.com/journal/125/61/1/suppl
XP002788981
[retrieved on  2019-03-04]
1-16
the whole document
(3)
Y
FENG R N ET AL, "Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial", DIABETOLOGIA,Vol. 56, No. 5, May 2013 (2013-05), page 985-994,
XP002789399
1-16
abstract
(4)
Y
NIU YU-CUN ET AL, "Histidine and arginine are associated with inflammation and oxidative stress in obese women", BRITISH JOURNAL OF NUTRITION,Vol. 108, No. 1, July 2012 (2012-07), page 57-61,
XP002789400
1-16
abstract
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"D"
document cited by the applicant in the international application
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
13 November 2019
Date of mailing of the international search report:
29 November 2019
Authorized officer:
Merckling-Ruiz, V
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E